Fresenius Kabi is a global healthcare company headquartered in Germany and part of the Fresenius Group. It develops, manufactures, and supplies generic injectable medicines, infusion therapies, and clinical nutrition products, along with related medical devices for infusion, transfusion, and nutrition.
The company’s portfolio spans sterile injectables such as anti-infectives, anesthesia, and oncology medicines; large-volume parenteral and specialty infusion solutions; and parenteral and enteral nutrition. Fresenius Kabi also offers infusion and nutrition pumps, disposables, and selected biosimilars. Its manufacturing network emphasizes aseptic processing, sterile filling, lyophilization, and GMP compliance, serving hospitals, outpatient care, and compounding services worldwide.
chemXplore tracks 1 project involving Fresenius Kabi.
Fresenius Kabi's role on them: Owner.
Two new antibiotic production lines added, creating 80 jobs with a €17 million investment. The plant now spans 6,000 square meters and employs around 600 people.
By country, the most active first. active / all projects
